论文部分内容阅读
目的分析男性糖尿病足患者应用前列地尔治疗的效果。方法随机选择2015年1月—2016年1月在该院接受治疗的男性糖尿病足患者50例参与研究,随机平均分成两组,对照组利用丹参酮注射液进行治疗,观察组选择前列地尔进行治疗,比较两组效果。结果观察组治疗总有效率为96.00%,对照组治疗总有效率68.00%;观察组治疗后胭动脉及足背动脉管径分别为(0.55±0.14)、(0.20±0.04)cm,对照组分别为(0.45±0.12)、(0.15±0.03)cm;两组患者治疗后低密度脂蛋白、空腹血糖、高密度脂蛋白、胆固醇、甘油三酯生化指标结果比较差异无统计学意义(P>0.05)。结论前列地尔治疗男性糖尿病足患者效果更为明显,安全性有保证,值得推广。
Objective To analyze the effect of alprostadil treatment in male patients with diabetic foot. Methods A total of 50 male patients with diabetic foot treated in our hospital from January 2015 to January 2016 were selected and randomly divided into two groups. The control group was treated with tanshinone injection, and the observation group was treated with alprostadil , Compare two groups effect. Results The total effective rate was 96.00% in the observation group and 68.00% in the control group. The diameters of the popliteal artery and dorsalis pedis artery in the observation group were (0.55 ± 0.14) and (0.20 ± 0.04) cm, respectively (0.45 ± 0.12) and (0.15 ± 0.03) cm. There was no significant difference in biochemical indexes of LDL, fasting blood glucose, HDL, cholesterol and triglyceride between the two groups after treatment (P> 0.05 ). Conclusion Alprostadil treatment of male patients with diabetic foot effect is more obvious, safety is guaranteed, it is worth promoting.